Cargando…
Is adalimumab protective in ischemia-reperfusion injury in lung?
OBJECTIVE(S): Increasing cytokines and reactive oxygen species (ROS) during ischemia reperfusion (I-R) leads to the lung damage. Adalimumab (Ada) is a potent tumor necrosis factor-alpha (TNF-α) inhibitor agent. We aimed to evaluate whether Ada would prevent the lung tissue from damage development ov...
Autores principales: | Kurt, Aysel, Tumkaya, Levent, Kalkan, Yildiray, Turut, Hasan, Cure, Medine Cumhur, Cure, Erkan, Sehitoglu, Ibrahim, Bilgin, Hacer, Usta, Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764110/ https://www.ncbi.nlm.nih.gov/pubmed/26949496 |
Ejemplares similares
-
The protective effect of infliximab against carbon tetrachloride-induced acute lung injury
por: Kurt, Aysel, et al.
Publicado: (2016) -
Adalimumab Ameliorates Abdominal Aorta Cross Clamping Which Induced Liver Injury in Rats
por: Cure, Erkan, et al.
Publicado: (2014) -
Investigation of surfactant protein-D and interleukin-6 levels in patients with blunt chest trauma with multiple rib fractures and pulmonary contusions: a cross-sectional study in Black Sea Region of Turkey
por: Kurt, Aysel, et al.
Publicado: (2016) -
Effect of infliximab against cisplatin-induced nephrotoxicity
por: Cure, Erkan, et al.
Publicado: (2014) -
Topiramate ameliorates abdominal aorta cross-clamping induced liver injury in rats
por: Cure, Erkan, et al.
Publicado: (2014)